Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB02379 | Beta-D-Glucose | 1 | Completed | 1 |
| DB00958 | Carboplatin | 1 | Completed | 1 |
| DB00531 | Cyclophosphamide | 1 | Completed | 1 |
| DB00773 | Etoposide | 1 | Completed | 1 |
| DB01181 | Ifosfamide | 1 | Completed | 1 |
| DB06176 | Romidepsin | 1 | Completed | 1 |
| DB17404 | AFM-13 | 1 / 2 | Active Not Recruiting | 1 |
| DB18674 | Acimtamig | 1 / 2 | Active Not Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 / 2 | Active Not Recruiting | 1 |
| DB01073 | Fludarabine | 1 / 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Active Not Recruiting | 1 |
| DB06813 | Pralatrexate | 1 / 2 | Active Not Recruiting | 1 |
| DB08870 | Brentuximab vedotin | 2 | Withdrawn | 1 |
| DB09037 | Pembrolizumab | 2 | Withdrawn | 1 |